What is CAGR? What does CAGR table indicate for Emmessar Biotech & Nutrition Ltd.?

Compounded average growth rate (CAGR) measures the average annual growth rate compounded year-on-year over a period of time.

Emmessar Biotech & Nutrition Ltd. Stock Analysis

Q: Is Emmessar Biotech & Nutrition Ltd. a good quality company?

MoneyWorks4Me analysed the past 10-year performance of Emmessar Biotech & Nutrition Ltd. and arrived at the following conclusion.

Small Cap

Evaluated by 145 users | BSE: 524768 | NSE: |
Pharmaceuticals & Drugs

Emmessar Biotech & Nutrition Ltd., was originally started as Emmessar Chemical Industries Ltd on March 17,1992, for manufacturing Super Speciality Fine Chemicals. The Company succeeded in developing many Speciality Fine Chemicals in its own In-house R&D, which was recognised...

10 Year X-Ray

Standalone basis Standalone basis P Consolidated basis

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

What is a Financial Track Record? How to read this chart in order to understand the data present here?

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Return on Capital Employed	-7.47%	-11.88%	-0.29%	-8.83%	-16.99%	-7.97%	15.68%	79.06%	36.06%	22.38%

Growth Parameters	Growth Parameters Colour Code Guide

Net Sales (Rs. Cr.)	5.8	3.9	3.2	0.6	1.4	2.2	2	2.6	1.3	0.6
Y-o-Y Gr. Rt.	-	-32.7%	-17.7%	-81.9%	136.2%	59.9%	-10.1%	33.5%	-52.5%	-49.6%
Adjusted EPS (Rs.)	-0.39	-0.55	-0.02	-0.36	-0.6	-0.24	0.36	2.36	1.83	1.47
Y-o-Y Gr. Rt.	-	NA	NA	NA	NA	NA	NA	555.6%	-22.5%	-19.7%
Book Value per Share (Rs.)	4.76	4.2	4.15	3.78	3.16	2.75	1.82	4.18	5.97	7.02
Adjusted Net Profit	-0.2	-0.3	0	-0.2	-0.3	-0.1	0.2	1.2	0.9	0.7
Net Op. Cash Flow (Rs. Cr.)	0	-0.1	0	0	0	0	0.4	0.8	0.7	0.4
Debt to Cash Flow from Ops	0	0	0	0	0	0	0	0	0	0.18

Difference between Standalone Basis and Consolidated basis? Which method is preferred for Emmessar Biotech & Nutrition Ltd. ?

Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.

Emmessar Biotech & Nutrition Ltd. should be analysed on a Standalone basis

CAGR CAGR Colour Code Guide

	9 yrs	5 yrs	3 yrs	1 yr
Net Sales	-21.8%	-14.4%	-31.6%	-49.6%
Adjusted EPS	NA	NA	59.8%	-19.7%
Book Value per Share	4.4	17.3	56.8	17.6
Share Price	22.5%	11.5%	-8.4%	118.7%

Key Financial Parameter	Performance Ratio Colour Code Guide

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Return on Equity (%)	-7.68	-11.98	-0.38	-8.9	-17.08	-8.08	15.6	78.58	36	22.6
Operating Profit Margin (%)	-2.46	-7.58	0.05	-32.94	-3.92	-6.54	0.63	8.64	-33.25	-101.55
Net Profit Margin (%)	-3.34	-7.08	-0.26	-31.36	-22.04	-5.45	9.02	44.75	72.9	116.54
Debt to Equity	0	0	0	0	0	0	0	0	0	0.02
Working Capital Days	39	150	307	1,828	477	126	175	152	333	905
Cash Conversion Cycle	11	15	14	362	76	63	64	40	39	187

Management X-Ray

Shareholding Pattern

Entity	Percentage Holding
Promoters	58.46%
Institutions	0.20%
Non-Institutions	41.35%

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

FAQs

1. Is Emmessar Biotech & Nutrition Ltd. a good quality company?

Data is not available for this company.

2. Is current market price of Emmessar Biotech & Nutrition Ltd. a good price to buy it?

The 5-year analysis of Emmessar Biotech & Nutrition Ltd.'s performance infers:

Emmessar Biotech & Nutrition Ltd. earnings have grown by 0%, whereas share price has appreciated 11.5% CAGR over the past five years, indicating the company's share price is likely overvalued. However, for specific investment actions please connect with your investment advisor.

3. What is Emmessar Biotech & Nutrition Ltd. share price return in the past 10 years ?

We analysed the performance of Emmessar Biotech & Nutrition Ltd. share prices over the last 10 years. Here is what we found out:

Emmessar Biotech & Nutrition Ltd. share price has appreciated 13% annually over the past ten years.

About Company

When there was a realisation that some of the Speciality Chemicals developed in our R&D and

When there was a realisation that some of the Speciality Chemicals developed in our R&D and exported to USA & Europe were being used in Healthcare formulations, the Company decided to re-orient itself and enter the Healthcare business, which is poised for phenomenal growth in the coming decades.

Concurrently the company also realised that some of the Speciality Chemicals are actually Vital Micro Nutrients, which are being used in the research worldwide as tools of Biotechnology, the Company took a conscious decision to enter the field of Biotechnology & Healthcare.

To ensure that the name is representative of its activity, the company's name was changed from Emmessar Chemical Industries Ltd., to Emmessar Biotech & Nutrition Ltd., on 7th April 2000.

In the process of pursuing its own R&D and exploring commercial market potentials for their products in the field of Healthcare, the company came across another reputed company in USA Vibrant Life in California.

Intense exchange of ideas & technical information between Emmessar Biotech & Nutrition Ltd., & Vibrant Life, resulted in development of several new concepts and new technologies - combining different schools of thought such as Nutraceuticals, Cosmeceuticals, Ayurveda & Biotechnology.

The company has developed many products covering different areas of healthcare that include obstinate Skin problems & debilitating chronic physical ailments.

Emmessar Biotech & Nutrition Ltd., is a Public Limited Company, with the Paid-up Share Capital of about Rs. 50.00 million (over $ 1.00 million). The Stocks of Emmessar Biotech & Nutrition Ltd., are traded in The Bombay Stock Exchange Ltd.

Product range of the company includes:

Present products